Tickers

1. Composite Trajectory Verdict

For a pre-revenue semiconductor IP licensing company, the balance sheet (liquidity/runway) and cash flow statement (operating burn rate) matter most because revenue is negligible and operations are funded entirely by equity issuance.

Composite Trajectory: Mixed

The income statement shows deteriorating trends: revenue fell 52% year-over-year in 2025 ($65K vs $135K) and remained minimal in H1 2026 ($169K), while operating expenses rose 7.8% in 2025 and 22.9% in H1 2026, widening net losses annually (-$20.2M vs -$18.4M) and in H1 2026 (-$12.4M vs -$10.2M). Operating cash burn increased annually (-$14.9M vs -$13.2M) and was flat in H1 2026 (-$8.5M vs -$8.3M). Conversely, the balance sheet improved sharply in H1 2026 due to a $23.6M registered direct offering and $3.1M ATM proceeds, raising cash and short-term investments from $19.2M to $38.4M and equity from $18.4M to $37.1M. Thus, operating fundamentals are deteriorating while liquidity has been bolstered by financing.

2. Red Flags

• Revenue declined 52% YoY in 2025 ($65K vs $135K) and remains negligible against ~$20.9M operating expenses (10-K 2025-12-31, Consolidated Statements of Operations).
• Cost of revenue exceeded revenue in 2025 ($321K vs $65K) and in H1 2026 ($152K vs $169K), producing negative gross margins (10-K 2025-12-31, Consolidated Statements of Operations; 10-Q 2026-06-30, Condensed Statements of Operations).
• Operating expenses rose 7.8% YoY in 2025 ($20.9M vs $19.3M) and 22.9% YoY in H1 2026 ($13.1M vs $10.7M), driven by G&A (+33%) and S&M (+223%) in H1 2026 (10-K 2025-12-31, MD&A; 10-Q 2026-06-30, MD&A).
• Net loss widened annually (-$20.2M vs -$18.4M) and in H1 2026 (-$12.4M vs -$10.2M) (10-K 2025-12-31, Consolidated Statements of Operations; 10-Q 2026-06-30, Condensed Statements of Operations).
• Operating cash burn increased annually (-$14.9M vs -$13.2M) and was flat in H1 2026 (-$8.5M vs -$8.3M) (10-K 2025-12-31, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, Condensed Statements of Cash Flows).
• Total reliance on equity financing: $7.6M ATM proceeds in 2025, $3.1M ATM plus $23.6M registered direct in H1 2026 (10-K 2025-12-31, MD&A; 10-Q 2026-06-30, MD&A).
• Stock-based compensation surged 28% in 2025 ($4.96M vs $3.87M) and 38% in H1 2026 ($3.15M vs $2.29M), reaching ~24% of operating expenses (10-K 2025-12-31, Notes to Financial Statements; 10-Q 2026-06-30, Notes).
• Revenue concentration: two customers represented 100% of revenue in 2025 (77%/23%) and 2024 (63%/37%) (10-K 2025-12-31, Notes to Financial Statements).
• Accumulated deficit grew to $241.7M at Dec 31 2025 and $254.1M at June 30 2026 (10-K 2025-12-31, Consolidated Balance Sheets; 10-Q 2026-06-30, Condensed Balance Sheets).
• Financing lease for epi tool being paid down ($1.16M principal in 2025, $420K in H1 2026) while new Tempe office operating lease added $342K ROU asset/liability in H1 2026 (10-K 2025-12-31, Notes; 10-Q 2026-06-30, Notes).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

Revenue fell from $135K in 2024 to $65K in 2025 and, while H1 2026 revenue rose to $169K from $4K in H1 2025, it remains trivial relative to operating expenses (10-K 2025-12-31, Consolidated Statements of Operations; 10-Q 2026-06-30, Condensed Statements of Operations). Total operating expenses increased 7.8% in 2025 ($20.9M vs $19.3M) and 22.9% in H1 2026 ($13.1M vs $10.7M), with G&A up 33% and S&M up 223% in H1 2026 (10-Q 2026-06-30, MD&A). Consequently, loss from operations widened to -$21.1M in 2025 from -$19.3M in 2024, and to -$13.1M in H1 2026 from -$10.7M in H1 2025 (10-K 2025-12-31, Consolidated Statements of Operations; 10-Q 2026-06-30, Condensed Statements of Operations). Net loss followed the same pattern: -$20.2M vs -$18.4M annually and -$12.4M vs -$10.2M for H1 (same sources). Gross margin stayed negative in 2025 (-$256K) and H1 2026 ($17K positive only because cost of revenue timing differs from revenue recognition) (10-K 2025-12-31, Consolidated Statements of Operations; 10-Q 2026-06-30, Condensed Statements of Operations).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Operating cash burn worsened annually: -$14.9M in 2025 vs -$13.2M in 2024 (10-K 2025-12-31, Consolidated Statements of Cash Flows). In the comparable six-month periods, operating cash used was nearly flat: -$8.5M in H1 2026 vs -$8.3M in H1 2025 (10-Q 2026-06-30, Condensed Statements of Cash Flows). However, financing cash flows improved dramatically: $27.6M in H1 2026 (driven by $23.6M registered direct offering and $3.1M ATM) vs $3.5M in H1 2025 (10-Q 2026-06-30, Condensed Statements of Cash Flows). Investing cash flow swung to -$23.1M in H1 2026 (purchase of short-term investments) from +$1.0M in H1 2025 (maturities) (10-Q 2026-06-30, Condensed Statements of Cash Flows). Net cash change was -$4.1M in H1 2026 vs -$3.8M in H1 2025, but total liquid resources (cash + short-term investments) rose from $19.2M to $38.4M (10-Q 2026-06-30, Condensed Balance Sheets; 10-Q 2026-06-30, Notes). Thus, operating cash generation is stable-to-worsening, while total liquidity improved via financing.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

The only comparable year-over-year balance sheets are the annual ones: total current assets fell from $27.1M at Dec 31 2024 to $19.6M at Dec 31 2025, cash dropped from $25.8M to $19.2M, and stockholders' equity declined from $25.1M to $18.4M (10-K 2025-12-31, Consolidated Balance Sheets). Working capital decreased from ~$23.5M to ~$17.6M (10-K 2025-12-31, MD&A). Quarterly balance sheets (June 30 2026 vs Dec 31 2025) show improvement — cash plus short-term investments rose to $38.4M and equity to $37.1M — but a June 30 2025 balance sheet is not provided, so a YoY quarterly trend cannot be computed (10-Q 2026-06-30, Condensed Balance Sheets). Based on the available annual YoY comparison, the balance sheet deteriorated.

6. Data Gaps

• Quarterly balance sheets for June 30 2025 and March 31 2025 (to enable YoY quarterly balance sheet trends).
• Revenue disaggregation by license type (R&D, HVM, MSTcad, engineering services) beyond aggregate figures.
• Customer pipeline, contract backlog, or milestone payment schedules.
• Detailed breakdown of "other operating items" in segment expense presentation.
• Terms and potential royalty rates under existing license agreements.
• Section 382 ownership change analysis for 2025 (only rolled through 2024).